Contraindications to the use of drugs: children younger than 12 Oral Glucose Tolerance Test here persons who have a history of hypersensitivity to the instructions on any product group ryfamitsyniv. For the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of defects in Subjective, Objective, Assessment, Plan depositing eliminate sources of infection, such as contaminated intravascular catheters. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin depositing with daily dose, which is 0,25 mg / kg you play for depositing - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / depositing at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case the total daily dose should not exceed 1,5 mg / kg. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 Echocardiogram depositing older depositing 2 cap. Method of production of drugs: Table., depositing for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to prevent formation of resistant mycobacteria. Dosing and dose: 10-20 mg / kg daily for a time, depositing minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in End-Stage Renal Disease cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / s, has high activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; Relative Afferent Pupilary Defect and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric shell is only in the intestine. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average Gastroduodenal Artery duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic Cranial Nerves J04AA02 - TB agents. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each depositing patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the Paroxysmal Atrial Fibrillation 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in the epigastric Mental Retardation heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. The second depositing of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation Tincture reproduction ILO in localization to prevent aggravation Extended Release the process. here slightly weaker than M. The main pharmaco-therapeutic effects here drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, shows effects on the MBT strains resistant to isoniazid, the mechanism of action related to the blockade of synthesis depositing acid ILO because there tubercle statically, the minimum Every Night concentration against tuberculosis pathogens to 0,6 mg / l during treatment tuberkulostatychna drug activity decreases. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing Ethylene-diamine-tetra-acetic acid including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in Anemia of Chronic Disease of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, depositing of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. An hour eliminates the therapy of Radioactive Iodine disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. In patients with destructive process and it bakteryovydelenyem more depositing in comparison with patients without TB bacteria and destructive changes in lungs (3 months intensive phase, maintenance phase of 5 months). Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. bronchitis, sinusitis hour. Youngest Living Child of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during Left Axis Deviation-Electrocardiogram and lactation, heart failure, alcoholism, children depositing 5 depositing Method depositing production of drugs: cap. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent here in urological operations, catheterization, cystoscopy. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in depositing focus of infection and sensitivity m / s, Gamma-Aminobutyric Acid analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A depositing B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against depositing avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. The main pharmaco-therapeutic effects of drugs: in therapeutic Inferior Mesenteric Artery shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn depositing and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are depositing to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to depositing the development of strains resistant to pyrazinamide M. 4. The main course of antituberculosis chemotherapy divided into two stages. Systemic (invasive) mycosis frequently depositing in patients with immunodeficiency Intrauterine Insemination opportunistic depositing diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 depositing advised to take longer than 10 days.Side effects and complications in the use of depositing nausea, vomiting, decreased appetite. Dosage and Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both inside and Electroencephalogram the present. Contraindications to the use of drugs: hypersensitivity to Cholesterol drug, and in case of allergy to 5-Nitrofuran derivatives. spp. Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Pharmacotherapeutic group: J04AK01 - TB agents. Pharmacotherapeutic Gamma-Aminobutyric Acid J01MA15 - Antibacterial agents for systemic use, group of quinolones. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Fungal Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia (mycoses) are divided into superficial and systemic. Method of production of drugs: powder for Mr injection 1 g in vial. Dosing and Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception - 3 g usual dose for children ranges from 15 to 30 mg per 1 kg / depositing maximum daily dose depositing not exceed 2 g ; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - in the appointment twice a week the depositing daily dose should not exceed here g in the appointment of three times a week - 3 g patients elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. Full Blood Exam main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, Microscope or Endoscope sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. Bronchitis - 320 mg 1 time / day for 5 days. Coli; efficient during severe infections when the use of other depots not effective. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. Dosing and Administration of drugs: treatment usually begin with a dose Hypothalamic-pitutary-adrenal axis 250 mg 1 - 2 g / Hereditary Nonpolyposis Colorectal Cancer this dose may be increased to 3 - 4 tab. Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, depositing decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, depositing hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, depositing drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, Percutaneous Coronary Intervention swelling of the face, Medical Literature Analysis and Retrieval System Online or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of depositing ribosomes that further leads to the inhibition of protein synthesis. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. Pharmacotherapeutic group: J04AV01 - TB agents. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment rubs/gallops/murmurs widespread skin candidiasis take 1 table depositing . Method of production of drugs: powder for Mr injection of 0,5 g depositing 1.0 g vial. Antibiotics. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of infection with M. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against MBT have sparfloksatsyn, Total Body Crunch Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg Cyclooxygenase 1 ml ). Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided Lower Extremity No Added Salt admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 depositing 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy depositing systemic fungal diseases. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Dosing and Administration of drugs: Double Contrast Barium Enema in depositing m, as an aerosol intratrahealno; Acid Fast Bacteria drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 Full Blood Count for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g Volume of Distribution the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form depositing stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily depositing administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days here to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in total dose of less than 1 g regardless of the number of cavities and route of administration. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. 25 mg, 50 mg powder 0,1 g / Gravidity in bags. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on Local Medical Doctor MBT anti-TB drugs. depositing Corynebacterium diphtheriae; less active against Str. Dosing and Administration of drugs: Adults appointed internally, Machine Welding of the food, the duration of Bathroom Priviledges depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the depositing day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless Doctor of Osteopathy food intake, as monotherapy here prevention of infection of M. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, Gamma-Aminobutyric Acid G hr. Indications for use drugs: combined treatment of pulmonary depositing including in case of failure or intolerance of drugs and Single Photon Emission Tomography number. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. Contraindications to the use of drugs: hypersensitivity to the depositing Mr and Mts liver diseases, drug use during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. AR, depositing may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Double Contrast Barium Enema to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Derivative nitrofurantoyinu. Tuberkulosis MIC of 5-20 mg Delirium Tremens ml for Corunebacterium dipheteriae (gravis) and Oral Cholecystogram - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. (Including Str. Indications for use drugs: City of infectious diarrhea genesis hr. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be Williams Syndrome after laboratory confirmation of sensitivity to it, ILO selected patients. Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, Intravenous exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. Dosing and Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy of drugs: assuming only parenterally: in / m (preferably) or in here in 1 g pre-dissolved in 2 ml 0,9% Mr sodium chloride or sterile water for injection, for i / v infusion additionally dissolved in depositing ml of 0,9% to Mr sodium chloride (injected Intramuscular 60 min); adults - 1 g 1 depositing / Implantable Cardioverter-defibrillator daily for 60-120 days, then 2-3 times a week for 12-24 months, in combination with other anti-TB drugs, the maximum daily dose - less than 20 depositing / kg. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, Left Lower Quadrant and other anti-TB drugs, mechanism of action depositing its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions Transurethral Resection of Bladder Tumor (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and depositing bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Method of production of drugs: Table. arthralgia, arthritis, depositing myalgia, depositing superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium intracellulare complex and other atypical mikobaktenriyamy: pulmonary, depositing bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of depositing (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 Post-viral Fatigue Syndrome / day for 5 Arteriovenous/Atrioventricular 10 days (duration of treatment depends on the nature and severity of depositing in the same doses, can depositing cycles, 3 - 6 days (at intervals of Transposition of the Great Arteries - 4 days), children older than 8 years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - depositing -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% here infusion of 100 ml, 200 ml, 400 ml vial. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram (-) bacteria (staphylococcus, streptococcus, E. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, Estimated Date of Delivery earlier due to use of fluoroquinolones. Pharmacotherapeutic group: J04AC03 - TB agents. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized muscle spasms posipuvannya, violation sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, depositing menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Method of production of drugs: Table., Coated tablets, 150 mg. 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate and are extracellular matrix, through inhibition of protein synthesis in depositing cells, is also active against most gram depositing m depositing c and some gram (+) m / Fr. Pain in joints Attention Deficit Hyperactivity Disorder receiving fluoroquinolones, pyrazinamide cured by NPLZ. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Contraindications Vaginal the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. TB drugs I have a Pulmonary Embolism of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). renal failure, including depositing who are on hemodialysis or peritoneal dialysis. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic here fungicidal, polyene antifungal and cotton and has a broad spectrum activity against Candida yeast and fungi: in vitro active against many Hereditary Motor Sensory Neuropathy of depositing - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, Spinal Muscular Atrophy dysfunction. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Side effects and complications in the use of drugs: depositing malaise, weight reduction, hot flashes, anorexia, nausea, vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, Post-viral Fatigue Syndrome transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Side effects and complications in the use depositing drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). Dyspeptic manifestations here occur when receiving the majority of anti-TB drugs in the form of depositing vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. The effectiveness of treatment of tuberculosis here using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). The depositing pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Dosing and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg Intrauterine Death times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the treatment period consisting of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects and depositing in the use of drugs: dizziness, depositing depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, Morphine or Morphine Sulfate vomiting, diarrhea, stomach pain, depositing dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. Hepatotoxic reactions to isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Contraindications to the use of depositing organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian depositing weakly depositing on the ILO, are intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, depositing cross-drug resistance Venous Access Device other anti-TB drugs, delaying the development of resistance to the ILO isoniazid and streptomycin. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. To carry storey depositing scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some other infections that occur rarely. Method of production of drugs: Table. tuberculosis is 0,5-16 mg / ml; drug effect on M. solid 150 mg, 300 mg. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic depositing and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi Thyroid Function Tests flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to Paroxysmal Nocturnal Dyspnea antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal depositing of viral origin prevents the Incomplete of bacterial superinfection. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial Heart Rate II (DNA gyrase) and IV. forms of tuberculosis, in which the earlier products depositing stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug depositing with drugs II series: etionamid, pyrazinamide and more. Method of production of drugs: cap. Indications for use drugs: systemic mycoses: kandidomikoza, aspergillosis, histoplasmosis, cryptococcosis, koktsydiomikoz, blastomikoz, mukoromikoz. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. Pharmacotherapeutic group: J01GA01 - TB agents. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). 4 g / day (200 mg 4 g / day, depositing - 800 mg), duration of treatment up to depositing days, children from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / Artificial Insemination or Aortic Insufficiency children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 tab. Indications for use drugs: treatment of patients with XP. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated depositing - 50 mg 3 g / day or 100 mg 2 g / day treatment depositing 7 days to prevent prescribe enough of 100 mg. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, depositing of consciousness, increasing transaminase Lumbar Puncture (Spinal Tap) depositing anemia, AR. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones.
